Quick Answer
ENANTA PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $32.30 million for the year ending 2025.
- ENANTA PHARMACEUTICALS INC showed a decrease of -13.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ENANTA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on November 19, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ENANTA PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 6,830.9%.
- Historical annual values: Fiscal year 2025: $32.30 million | Fiscal year 2024: $37.23 million | Fiscal year 2023: $85.39 million | Fiscal year 2022: $43.99 million | Fiscal year 2021: $57.21 million | Fiscal year 2020: $87.13 million | Fiscal year 2019: $51.23 million | Fiscal year 2018: $63.90 million | Fiscal year 2017: $65.68 million | Fiscal year 2016: $16.58 million | Fiscal year 2015: $21.73 million | Fiscal year 2014: $30.70 million | Fiscal year 2013: $8.86 million | Fiscal year 2012: $10.51 million | Fiscal year 2011: $6.84 million | Fiscal year 2010: $466.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: